{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T17:53:08Z","timestamp":1786816388027,"version":"build-2736575974"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunogenic cell death (ICD) influences tumor immune microenvironment remodeling and immunotherapy response. However, the prognostic value of ICD-related genes in colon cancer has not been systematically clarified. This study aimed to develop an ICD-based prognostic model and explore its association with the immune microenvironment and treatment sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Transcriptomic and clinical data of colon adenocarcinoma (COAD) patients were obtained from TCGA and GTEx, with GSE17538 and GSE38832 used as external validation cohorts. Single-cell RNA-seq data from the Colon Cancer Atlas were analyzed to characterize ICD-associated T-cell states. Differentially expressed genes between high and low ICD-score T cells were identified using ssGSEA, followed by WGCNA to select immune-related modules. One hundred seventeen machine-learning model combinations were evaluated to construct the optimal prognostic signature. Immune infiltration was assessed using CIBERSORT, ssGSEA, and ESTIMATE. GSEA explored pathway differences, while drug sensitivity was predicted using pRRophetic. The top-weighted gene was validated through\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven major cell types were identified within the tumor microenvironment. T cells with high and low ICD scores exhibited distinct functional and spatial patterns. WGCNA identified a key module highly correlated with ICD scores, and 51 genes were screened. The Random Survival Forest model yielded a 15-gene ICD-related signature with strong prognostic performance (C-index 0.968 in TCGA; 0.767 and 0.855 in validation cohorts). High-risk patients consistently showed poorer survival (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). A combined nomogram demonstrated stable predictive accuracy. High-risk patients displayed increased M2 macrophages and Tregs, whereas low-risk patients exhibited higher activated CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells and plasma cells. EMT and angiogenesis pathways were enriched in the high-risk group, while metabolic pathways predominated in the low-risk group. High-risk patients were more sensitive to drugs such as Dasatinib. FCGR2A overexpression promoted proliferation, migration, and invasion\n                      <jats:italic>in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The 15-gene ICD-based model effectively predicts COAD prognosis, reflects immune microenvironment heterogeneity, and offers insights for individualized treatment planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1746907","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:25:21Z","timestamp":1769066721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-omics integration and machine learning-driven construction of an immunogenic cell death prognostic model for colon cancer and functional validation of FCGR2A"],"prefix":"10.3389","volume":"16","author":[{"given":"Haipeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital of Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12911-024-02525-z","article-title":"Improved nonparametric survival prediction using CoxPH, Random Survival Forest & DeepHit Neural Network","volume":"24","author":"Asghar","year":"2024","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"B2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.csbj.2022.01.003","article-title":"Random survival forest model identifies novel biomarkers of event-free survival in high-risk pediatric acute lymphoblastic leukemia","volume":"20","author":"Bohannan","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","article-title":"InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation","volume":"41","author":"Breuer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"837645","DOI":"10.3389\/fimmu.2022.837645","article-title":"The role of immune checkpoint molecules on macrophages in cancer, infection, and autoimmune pathologies","volume":"13","author":"Brom","year":"2022","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/jco.2018.36.4_suppl.587","article-title":"Estimating 1- and 5-year relative survival trends in colorectal cancer (CRC) in the United States: 2004 to 2014","volume":"36","author":"Crooke","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70041","DOI":"10.1002\/cam4.70041","article-title":"Molecular subtypes of colorectal cancer in the era of precision oncotherapy: current inspirations and future challenges","volume":"13","author":"Dang","year":"2024","journal-title":"Cancer Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ccr.2013.10.019","article-title":"A new twist on radiation oncology: Low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy","volume":"24","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"Fc\u03b3R binding and ADCC activity of human IgG allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1456719","DOI":"10.3389\/fimmu.2024.1456719","article-title":"Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma","volume":"15","author":"Fu","year":"2024","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.3390\/ijms22105246","article-title":"Heterogeneity of colorectal cancer progression: molecular gas and brakes","volume":"22","author":"Gaiani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1386829","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch: immunogenic cell death induction by anticancer chemotherapeutics","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamaoncol.2016.4884","article-title":"Association of polymorphisms in FCGR2A and FCGR3A with degree of trastuzumab benefit in the adjuvant treatment of ERBB2\/HER2-Positive breast cancer analysis of the NSABP B-31 trial","volume":"3","author":"Gavin","year":"2017","journal-title":"Jama Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"548719","DOI":"10.3389\/fgene.2020.548719","article-title":"Applications of single-cell omics to dissect tumor microenvironment","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.21037\/tcr-24-533","article-title":"Immunogenic cell death-related signature predicts prognosis and immunotherapy efficacy in bladder cancer","volume":"13","author":"Guo","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1431150","DOI":"10.3389\/fimmu.2024.1431150","article-title":"Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2303177","DOI":"10.1002\/advs.202303177","article-title":"NAMPT-driven M2 polarization of tumor-associated macrophages leads to an immunosuppressive microenvironment in colorectal cancer","volume":"11","author":"Hong","year":"2024","journal-title":"Adv. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00262-024-03829-9","article-title":"A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients","volume":"73","author":"Jiang","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"13","author":"Kourou","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinforma."},{"key":"B31","doi-asserted-by":"publisher","first-page":"616073","DOI":"10.3389\/fgene.2021.616073","article-title":"Comprehensive analysis of tumor microenvironment identified prognostic immune-related gene signature in ovarian cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/OTT.S521346","article-title":"Studying immunogenic cell death in human colorectal cancer organoids","volume":"18","author":"Lisandrelli","year":"2025","journal-title":"Oncotargets Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1344058","DOI":"10.3389\/fendo.2024.1344058","article-title":"PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e23501","DOI":"10.1016\/j.heliyon.2023.e23501","article-title":"Dasatinib suppresses collective cell migration through the coordination of focal adhesion and E-cadherin in colon cancer cells","volume":"10","author":"Lu","year":"2024","journal-title":"Heliyon"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/ATVBAHA.113.300168","article-title":"Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions","volume":"33","author":"Mantovani","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1532523","DOI":"10.3389\/fgene.2025.1532523","article-title":"Immunogenic cell death genes in single-cell and transcriptome analyses perspectives from a prognostic model of cervical cancer","volume":"16","author":"Ning","year":"2025","journal-title":"Front. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"33111","DOI":"10.18632\/oncotarget.8880","article-title":"Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src","volume":"7","author":"Perez","year":"2016","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","first-page":"551420","DOI":"10.3389\/fonc.2020.551420","article-title":"A comparison study of machine learning (random survival forest) and classic statistic (cox proportional hazards) for predicting progression in high-grade glioma after proton and carbon ion radiotherapy","volume":"10","author":"Qiu","year":"2020","journal-title":"Front. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/pharmaceutics14081564","article-title":"An overview on immunogenic cell death in cancer biology and therapy","volume":"14","author":"Rodrigues","year":"2022","journal-title":"Pharmaceutics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3324\/haematol.2016.148965","article-title":"Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia","volume":"102","author":"Shapiro","year":"2017","journal-title":"Haematologica"},{"key":"B44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/EDE.0000000000001188","article-title":"A cautionary note on extended kaplan-meier curves for time-varying covariates","volume":"31","author":"Sj\u00f6lander","year":"2020","journal-title":"Epidemiology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"bbaf150","DOI":"10.1093\/bib\/bbaf150","article-title":"A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables","volume":"26","author":"Tran","year":"2025","journal-title":"Brief. Bioinform"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.3389\/fimmu.2018.02582","article-title":"Single-cell transcriptomics in cancer immunobiology: the future of precision oncology","volume":"9","author":"Valdes-Mora","year":"2018","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10549-023-07231-4","article-title":"Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial","volume":"205","author":"Verschoor","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.22283\/qbs.2017.36.2.85","article-title":"A selective review on random survival forests for high dimensional data","volume":"36","author":"Wang","year":"2017","journal-title":"Quant. Biosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12957-021-02244-z","article-title":"Identification of a ferroptosis-related gene signature predictive model in colon cancer","volume":"19","author":"Wang","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","article-title":"Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.21037\/jgo-24-325","article-title":"Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer","volume":"15","author":"Xun","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"807410","DOI":"10.3389\/fonc.2021.807410","article-title":"Tumor immune microenvironment related gene-based model to predict prognosis and response to compounds in ovarian cancer","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12885-022-09344-3","article-title":"An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy","volume":"22","author":"Yang","year":"2022","journal-title":"Bmc Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1588703","DOI":"10.3389\/fonc.2025.1588703","article-title":"Immunogenic cell death-related genes as prognostic biomarkers and therapeutic insights in uterine corpus endometrial carcinoma: an integrative bioinformatics analysis","volume":"15","author":"Yi","year":"2025","journal-title":"Front. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e17629","DOI":"10.7717\/peerj.17629","article-title":"Prognostic and therapeutic insights into colorectal carcinoma through immunogenic cell death gene profiling","volume":"12","author":"Yu","year":"2024","journal-title":"Peerj"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1200\/JCO.2006.08.8021","article-title":"FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab","volume":"25","author":"Zhang","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1186\/s12885-024-13328-w","article-title":"Pathomics-based machine learning models for predicting pathological complete response and prognosis in locally advanced rectal cancer patients post-neoadjuvant chemoradiotherapy: insights from two independent institutional studies","volume":"24","author":"Zhang","year":"2024","journal-title":"Bmc Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e41380","DOI":"10.1016\/j.heliyon.2024.e41380","article-title":"Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma","volume":"11","author":"Zhang","year":"2025","journal-title":"Heliyon"},{"key":"B60","doi-asserted-by":"publisher","first-page":"9807918","DOI":"10.1155\/2020\/9807918","article-title":"Development of prognostic indicator based on autophagy-related lncRNA analysis in Colon adenocarcinoma","volume":"2020","author":"Zhou","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s13402-020-00552-2","article-title":"Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy","volume":"43","author":"Zhu","year":"2020","journal-title":"Cell Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1746907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:45:14Z","timestamp":1771919114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1746907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":61,"alternative-id":["10.3389\/fphar.2025.1746907"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1746907","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"article-number":"1746907"}}